FDA Approves CBD Treatment for Seizures in Two Rare and Severe Forms of Epilepsy

Epilepsy
August 7, 2020

FDA Approves CBD Treatment for Seizures in Two Rare and Severe Forms of Epilepsy

Epidiolex®, a cannabidiol (CBD) oral solution by Greenwich Biosciences, is now indicated for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS), Dravet Syndrome (DS) or Tuberous Sclerosis Complex in patients one year of age or older. Read more about this development in Drug Topics.